vs
Side-by-side financial comparison of EASTERN CO (EML) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $55.3M, roughly 1.0× EASTERN CO). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -22.4%). EASTERN CO produced more free cash flow last quarter ($3.1M vs $-167.0M).
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
EML vs PHAT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.3M | $57.6M |
| Net Profit | $578.9K | — |
| Gross Margin | 22.3% | 86.7% |
| Operating Margin | 3.1% | — |
| Net Margin | 1.0% | — |
| Revenue YoY | -22.4% | 94.1% |
| Net Profit YoY | 103.8% | 71.6% |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.6M | ||
| Q3 25 | $55.3M | $49.5M | ||
| Q2 25 | $70.2M | $39.5M | ||
| Q1 25 | $63.3M | $28.5M | ||
| Q4 24 | $64.3M | $29.7M | ||
| Q3 24 | $71.3M | $16.4M | ||
| Q2 24 | $72.6M | $7.3M | ||
| Q1 24 | $64.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | $578.9K | $-30.0M | ||
| Q2 25 | $3.4M | $-75.8M | ||
| Q1 25 | $1.9M | $-94.3M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $-15.3M | $-85.6M | ||
| Q2 24 | $3.5M | $-91.4M | ||
| Q1 24 | $1.9M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | 22.3% | 87.5% | ||
| Q2 25 | 23.3% | 87.2% | ||
| Q1 25 | 22.4% | 86.9% | ||
| Q4 24 | 23.6% | 87.1% | ||
| Q3 24 | 25.5% | 85.6% | ||
| Q2 24 | 25.4% | 81.2% | ||
| Q1 24 | 23.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.1% | -30.8% | ||
| Q2 25 | 4.5% | -151.7% | ||
| Q1 25 | 5.1% | -276.5% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 9.5% | -433.0% | ||
| Q2 24 | 8.3% | -1055.4% | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.0% | -60.5% | ||
| Q2 25 | 4.9% | -191.9% | ||
| Q1 25 | 3.1% | -330.7% | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | -21.5% | -523.3% | ||
| Q2 24 | 4.8% | -1248.6% | ||
| Q1 24 | 3.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | $0.10 | $-0.41 | ||
| Q2 25 | $0.56 | $-1.05 | ||
| Q1 25 | $0.32 | $-1.31 | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $-2.46 | $-1.32 | ||
| Q2 24 | $0.56 | $-1.56 | ||
| Q1 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.2M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $124.3M | $-438.2M |
| Total Assets | $220.0M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | $9.2M | $135.2M | ||
| Q2 25 | $9.1M | $149.6M | ||
| Q1 25 | $10.2M | $212.3M | ||
| Q4 24 | $16.1M | $297.3M | ||
| Q3 24 | $9.7M | $334.7M | ||
| Q2 24 | $2.0M | $276.2M | ||
| Q1 24 | $2.1M | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | $42.2M | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | $-438.2M | ||
| Q3 25 | $124.3M | $-422.5M | ||
| Q2 25 | $124.4M | $-405.8M | ||
| Q1 25 | $121.0M | $-338.4M | ||
| Q4 24 | $120.7M | $-253.6M | ||
| Q3 24 | $119.2M | $-187.1M | ||
| Q2 24 | $136.5M | $-233.8M | ||
| Q1 24 | $134.5M | — |
| Q4 25 | — | $259.1M | ||
| Q3 25 | $220.0M | $240.3M | ||
| Q2 25 | $229.4M | $250.2M | ||
| Q1 25 | $232.3M | $294.2M | ||
| Q4 24 | $235.3M | $378.3M | ||
| Q3 24 | $244.2M | $387.0M | ||
| Q2 24 | $255.9M | $319.4M | ||
| Q1 24 | $253.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.1M | $-166.8M |
| Free Cash FlowOCF − Capex | $3.1M | $-167.0M |
| FCF MarginFCF / Revenue | 5.5% | -290.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.4% |
| Cash ConversionOCF / Net Profit | 5.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.3M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-166.8M | ||
| Q3 25 | $3.1M | $-14.1M | ||
| Q2 25 | $3.8M | $-62.7M | ||
| Q1 25 | $-1.8M | $-84.9M | ||
| Q4 24 | $11.0M | $-266.8M | ||
| Q3 24 | $-2.9M | $-63.6M | ||
| Q2 24 | $8.4M | $-70.7M | ||
| Q1 24 | $2.8M | — |
| Q4 25 | — | $-167.0M | ||
| Q3 25 | $3.1M | $-14.1M | ||
| Q2 25 | $3.0M | $-62.8M | ||
| Q1 25 | $-2.7M | $-84.9M | ||
| Q4 24 | $9.0M | $-266.9M | ||
| Q3 24 | $-7.7M | $-63.6M | ||
| Q2 24 | $7.3M | $-70.8M | ||
| Q1 24 | $1.1M | — |
| Q4 25 | — | -290.0% | ||
| Q3 25 | 5.5% | -28.6% | ||
| Q2 25 | 4.3% | -159.0% | ||
| Q1 25 | -4.3% | -297.9% | ||
| Q4 24 | 13.9% | -899.8% | ||
| Q3 24 | -10.8% | -389.0% | ||
| Q2 24 | 10.1% | -966.2% | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 1.1% | 0.2% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 3.2% | 0.5% | ||
| Q3 24 | 6.7% | 0.3% | ||
| Q2 24 | 1.5% | 0.6% | ||
| Q1 24 | 2.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.38× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | -0.95× | — | ||
| Q4 24 | 8.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.40× | — | ||
| Q1 24 | 1.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
